• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸盐去除模型的修改与验证:一项多中心研究

Modification and Validation of the Phosphate Removal Model: A Multicenter Study.

作者信息

Zhang Weichen, Du Qiuna, Xiao Jing, Bi Zhaori, Yu Chen, Ye Zhibin, Wang Mengjing, Chen Jing

机构信息

Nephrology, Huashan Hospital, Fudan University, Shanghai, China.

Nephrology, Tongji Hospital, Tongji University, Shanghai, China.

出版信息

Kidney Blood Press Res. 2021;46(1):53-62. doi: 10.1159/000511375. Epub 2021 Jan 21.

DOI:10.1159/000511375
PMID:33477164
Abstract

BACKGROUND

Our research group has previously reported a noninvasive model that estimates phosphate removal within a 4-h hemodialysis (HD) treatment. The aim of this study was to modify the original model and validate the accuracy of the new model of phosphate removal for HD and hemodiafiltration (HDF) treatment.

METHODS

A total of 109 HD patients from 3 HD centers were enrolled. The actual phosphate removal amount was calculated using the area under the dialysate phosphate concentration time curve. Model modification was executed using second-order multivariable polynomial regression analysis to obtain a new parameter for dialyzer phosphate clearance. Bias, precision, and accuracy were measured in the internal and external validation to determine the performance of the modified model.

RESULTS

Mean age of the enrolled patients was 63 ± 12 years, and 67 (61.5%) were male. Phosphate removal was 19.06 ± 8.12 mmol and 17.38 ± 6.75 mmol in 4-h HD and HDF treatments, respectively, with no significant difference. The modified phosphate removal model was expressed as Tpo4 = 80.3 × C45 - 0.024 × age + 0.07 × weight + β × clearance - 8.14 (β = 6.231 × 10-3 × clearance - 1.886 × 10-5 × clearance2 - 0.467), where C45 was the phosphate concentration in the spent dialysate measured at the 45th minute of HD and clearance was the phosphate clearance of the dialyzer. Internal validation indicated that the new model was superior to the original model with a significantly smaller bias and higher accuracy. External validation showed that R2, bias, and accuracy were not significantly different than those of internal validation.

CONCLUSIONS

A new model was generated to quantify phosphate removal by 4-h HD and HDF with a dialyzer surface area of 1.3-1.8 m2. This modified model would contribute to the evaluation of phosphate balance and individualized therapy of hyperphosphatemia.

摘要

背景

我们的研究小组之前报告了一种非侵入性模型,该模型可估计4小时血液透析(HD)治疗过程中的磷清除情况。本研究的目的是修改原始模型,并验证用于HD和血液透析滤过(HDF)治疗的磷清除新模型的准确性。

方法

招募了来自3个HD中心的109例HD患者。使用透析液磷浓度时间曲线下的面积计算实际磷清除量。采用二阶多变量多项式回归分析进行模型修改,以获得透析器磷清除率的新参数。在内部和外部验证中测量偏差、精密度和准确性,以确定修改后模型的性能。

结果

入组患者的平均年龄为63±12岁,其中67例(61.5%)为男性。在4小时的HD和HDF治疗中,磷清除量分别为19.06±8.12 mmol和17.38±6.75 mmol,无显著差异。修改后的磷清除模型表示为Tpo4 = 80.3×C45 - 0.024×年龄 + 0.07×体重 + β×清除率 - 8.14(β = 6.231×10-3×清除率 - 1.886×10-5×清除率2 - 0.467),其中C45是HD第45分钟时测量的用过透析液中的磷浓度,清除率是透析器的磷清除率。内部验证表明,新模型优于原始模型,偏差显著更小,准确性更高。外部验证表明,R2、偏差和准确性与内部验证无显著差异。

结论

生成了一个新模型,用于量化透析器表面积为1.3 - 1.8 m2的4小时HD和HDF的磷清除情况。这个修改后的模型将有助于评估磷平衡和高磷血症的个体化治疗。

相似文献

1
Modification and Validation of the Phosphate Removal Model: A Multicenter Study.磷酸盐去除模型的修改与验证:一项多中心研究
Kidney Blood Press Res. 2021;46(1):53-62. doi: 10.1159/000511375. Epub 2021 Jan 21.
2
Phosphate removal model: an observational study of low-flux dialyzers in conventional hemodialysis therapy.磷酸盐清除模型:传统血液透析治疗中低通量透析器的观察性研究
Hemodial Int. 2012 Jul;16(3):363-76. doi: 10.1111/j.1542-4758.2012.00678.x. Epub 2012 Feb 23.
3
Comparison of measured vs kinetic-model predicted phosphate removal during hemodialysis and hemodiafiltration.比较血液透析和血液透析滤过过程中实测与动力学模型预测的磷酸盐清除率。
Nephrol Dial Transplant. 2022 Nov 23;37(12):2522-2527. doi: 10.1093/ndt/gfac223.
4
Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.血液透析滤过——血液透析患者高磷血症的一种新治疗选择。
Clin Nephrol. 1999 Sep;52(3):152-9.
5
A Clinical Significance of Intermittent Infusion Hemodiafiltration Using Backfiltration of Ultrapure Dialysis Fluid Compared to Hemodialysis: A Multicenter Randomized Controlled Crossover Trial.使用超纯透析液反超滤的间歇性输液血液透析滤过与血液透析的临床意义比较:一项多中心随机对照交叉试验。
Blood Purif. 2019;48(4):368-381. doi: 10.1159/000501511. Epub 2019 Jul 16.
6
Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.血液透析和腹膜透析方式中的磷酸盐清除。
Blood Purif. 2010;29(2):137-44. doi: 10.1159/000245640. Epub 2010 Jan 8.
7
Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.对流对维持性血液透析患者磷清除的影响
J Ren Nutr. 2006 Jan;16(1):47-53. doi: 10.1053/j.jrn.2005.10.008.
8
Phosphate Removal During Long Nocturnal Hemodialysis/Hemodiafiltration: A Study With Total Dialysate Collection.长时间夜间血液透析/血液透析滤过过程中的磷清除:一项全量透析液收集研究
Ther Apher Dial. 2016 Jun;20(3):267-71. doi: 10.1111/1744-9987.12435.
9
[Factors which influence phosphorus removal in hemodialysis].[影响血液透析中磷清除的因素]
Nefrologia. 2007;27(1):46-52.
10
Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial.
Nephrol Dial Transplant. 2017 May 1;32(5):855-861. doi: 10.1093/ndt/gfw085.

引用本文的文献

1
Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor.慢性肾脏病中的高磷血症:寻找新的治疗模式及替那帕诺的作用
Int J Nephrol Renovasc Dis. 2024 May 28;17:151-161. doi: 10.2147/IJNRD.S385826. eCollection 2024.
2
A New Calculation Model for Calcium Requirements After Parathyroidectomy in Patients With Secondary Hyperparathyroidism.继发性甲状旁腺功能亢进患者甲状旁腺切除术后钙需求量的新计算模型
Clin Exp Otorhinolaryngol. 2023 Aug;16(3):282-289. doi: 10.21053/ceo.2023.00584. Epub 2023 Jul 19.